CDT (CDT Equity) ROC (Joel Greenblatt) %: -12,251.51% (As of Dec. 2025)


CDT CDT Equity Inc CDT
10 GF Score
Price $0.58
! 5 Warning Signs
View Full Analysis

What is CDT Equity ROC (Joel Greenblatt) %?

CDT Equity CDT 10 ROC (Joel Greenblatt) % is -12,251.51% as of Dec. 2025. GuruFocus rates CDT with a GF Score™ of 10/100. The stock has 5 warning signs investors should review. Among 1,325 Biotechnology companies, CDT Equity ranks worse than 83.25% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. CDT Equity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -12,251.51%.

The historical rank and industry rank for CDT Equity's ROC (Joel Greenblatt) % or its related term are showing as below:

CDT' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -10897.76   Med: -3285.48   Max: 443.11
Current: -4283.75

During the past 5 years, CDT Equity's highest ROC (Joel Greenblatt) % was 443.11%. The lowest was -10897.76%. And the median was -3285.48%.

CDT's ROC (Joel Greenblatt) % is ranked worse than
83.25% of 1325 companies
in the Biotechnology industry
Industry Median: -297.52 vs CDT: -4283.75

CDT Equity's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


CDT Equity  (NAS:CDT) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


CDT Equity ROC (Joel Greenblatt) % Related Terms


CDT Equity ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for CDT Equity's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CDT Equity ROC (Joel Greenblatt) % Chart

CDT Equity Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
0.00 0.00 443.11 -3,285.48 -10,897.76

CDT Equity Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,799.07 -1,703.07 -1,677.25 -2,856.57 -12,251.51

CDT vs CLDI, DCOY, ACUT: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, CDT Equity's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CDT Equity ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CDT Equity's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where CDT Equity's ROC (Joel Greenblatt) % falls into.


CDT
10GF Score
CDT Equity Inc CDT
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CDT Equity ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 2.858) - (2.34 + 0 + 0.058)
=0.46

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 2.87) - (12.045 + 0 + 0)
=-9.175

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of CDT Equity for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-85.148/( ( (0.519 + max(0.46, 0)) + (0.411 + max(-9.175, 0)) )/ 2 )
=-85.148/( ( 0.979 + 0.411 )/ 2 )
=-85.148/0.695
=-12,251.51 %

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -12,251.51% mean?
CDT Equity (CDT) has a ROC (Joel Greenblatt) % of -12,251.51% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on CDT Equity and its competitors. According to the industry distribution chart, CDT Equity ranks #1103 out of 1325 companies in the Biotechnology industry, placing it in the top 83.2%.
Is CDT Equity's ROC (Joel Greenblatt) % too high?
CDT Equity's current ROC (Joel Greenblatt) % is -12,251.51%. Based on the distribution chart, CDT Equity ranks #1103 out of 1325 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CDT Equity has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CDT Equity's ROC (Joel Greenblatt) % compare to CLDI and DCOY?
According to the Biotechnology industry distribution chart, CDT Equity ranks #1103 out of 1325 companies for ROC (Joel Greenblatt) %. This places CDT Equity in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on CDT Equity and its competitors. CDT Equity's current ROC (Joel Greenblatt) % is -12,251.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CDT Equity stock overvalued right now?
CDT Equity (CDT) has a current ROC (Joel Greenblatt) % of -12,251.51%. The current ROC (Joel Greenblatt) % is -12,251.51%. CDT Equity's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For CDT Equity (CDT), the current ROC (Joel Greenblatt) % is -12,251.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CDT Equity Business Description

Address 4581 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
10GF Score

Get the complete analysis for CDT

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price